S 474
Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2019 requires drug manufacturers to publicly justify significant price increases for certain medications. Specifically, the bill targets drugs with substantial cost increases, demanding that manufacturers submit detailed justifications to the Centers for Medicare & Medicaid Services (CMS). CMS will then publish these justifications, along with a simplified summary, on its website, promoting greater transparency in drug pricing. Manufacturers who fail to comply could face financial penalties.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Benjamin L. Cardin
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.